Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (CSE: $CHV.C) (CSE: $HITI.C) (TSXV: $PCLO.V)
(CSE: $XPHY.C) (CSE: $MGRO.C)
Delta, Kelowna, BC, January 24, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/01271CHV-HITI-PCLO-XPHY-MGRO.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few of this week’s announcements.
Canada House
Wellness Group Inc. (CSE:
CHV)
announced that
its wholly owned subsidiary, Abba Medix Corp., has now registered its 100th medical patient in less
than three months. This news comes on
the heels of Abba's January 22, 2020 announcement that it has added three
additional strains to its product portfolio and now has a total of four strains
available for sale to registered Abba patients.
Abba anticipates its patient growth rates will rise sharply as awareness
of Abba's excellent variety of dried flower spreads throughout the Canadian
medical cannabis landscape, and more specifically to veteran medical
patients.
"A
key strategy of Canada House is to increase Abba's patient base by expanding
relationships with users of medical cannabis and cannabis clinics across the
country," says Canada House CEO Chris Churchill-Smith. "In addition, we have listened to our
patients and have increased the selection of cannabis products to meet their
needs. This important milestone drives
Canada House and Abba revenues and demonstrates progress on Canada House's Path
to Profitability."
"Registering
Abba's 100th medical patient is an important milestone for our
organization and is emblematic of our dedication to medical cannabis
patients. We are committed to offering
high quality strains that best serve those medical patients looking for
solutions to a variety of health and wellness needs and as Abba's patient base
continues to grow, we will strategically and selectively add complementary
strains that our patients covet," said Michael Orrbrooke, Abba's President
and the Chief Revenue Officer of Canada House.
"In addition to offering a more comprehensive selection of strains,
we intend to offer our products in new formats to provide our medical patients
with many options while maintaining our industry leading customer service and
online customer experience."
High Tide Inc. (CSE:HITI) (OTCQB:HITIF), an
Alberta-based, retail-focused cannabis corporation enhanced by the
manufacturing and wholesale distribution of smoking accessories and cannabis
lifestyle products, has
completed the acquisition of the Canna Cabana retail cannabis
store in Hamilton, Ontario. The acquisition of the Hamilton Store, one of a
limited number of premier cannabis retail stores operating in the province,
marks the Company's first step towards acquiring its interest in all three
current Canna Cabana locations across Ontario. The Hamilton Store has a strong
operating history with unaudited gross sales exceeding $14 million for the nine
months since opening on April 20, 2019, with gross margins of approximately
28%.
As
consideration for the acquisition, High Tide paid to the vendor $2,097,816 in
cash and issued to the Vendor 4,761,904 common shares in the capital of the
Company. The Transaction, which was completed with the consent of the Alcohol and
Gaming Commission of Ontario following the expiry of certain restrictions on
change of control established under the rules applicable to the first cannabis
retail lottery conducted by the AGCO on January 11, 2019. In connection with
the Transaction, the Company acquired all of the issued and outstanding shares
of a numbered company that was wholly-owned by the holder of a cannabis retail
store authorization issued by the AGCO in the First Lottery.
"High
Tide is excited to add the Hamilton store to its corporately-owned portfolio of
stores, with its large and loyal customer base and top-tier financial
performance," said Raj Grover, High Tide's President & Chief Executive
Officer. "Over the coming year, we look forward to growing our presence in
the Ontario market and reaching the maximum of 10 stores per operator as
quickly as possible," Mr. Grover added. Through this Transaction, High
Tide has made its first move towards significantly expanding its retail network
in Canada's most populous province.
PharmaCielo Ltd. (TSXV:
PCLO) (OTCQX:
PCLOF), the Canadian parent of Colombia's premier cultivator
and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia
Holdings S.A.S., announced that it
has entered into a three-year agreement with XPhyto Therapeutics Corp. (CSE:XPHY),
whereby PharmaCielo will supply medicinal-quality cannabis extract oils and
isolates, including those containing THC, to XPhyto for analysis, further
processing, product development and manufacturing at its European Union Good
Manufacturing Practice-certified facility in Biberach in the state of
Baden-Württemberg, and thereafter for sale into the German market.
"PharmaCielo
has a significant opportunity to export an ever-expanding range of medicinal
products into the German market, including those containing THC, and we are
very excited to work with XPhyto to leverage this opportunity," said David
Attard, CEO of PharmaCielo Ltd. "As the largest medicinal cannabis
marketplace in Europe, Germany is also the most demanding in terms of product
quality. Our ability to meet market
requirements for verifiable quality parameters was essential to establishing
the relationship. We expect to generate meaningful revenue through this
agreement over the next three years and are focused on continuing the ramp-up
of our sales efforts through 2020."
XPhyto
is a Canadian headquartered company focused on cannabinoid-based formulations
and clinical validations. The company
owns two German subsidiaries, Bunker Pflanzenextrakte GmbH and Vektor Pharma TF
GmbH, and is expanding its current licensed German cultivation, processing and
product R&D to address near-term medicinal product opportunities in the
German marketplace.
MustGrow Biologics
Corp. (CSE:
MGRO) (OTC:
MGROF), an agricultural biotech company developing and
commercializing a portfolio of natural, science-based biological crop
protection products, announced
the
filing of patents related to method-of-use
and composition-of-matter claims for
a biological non-selective bio-herbicide, based on MustGrow’s signature
mustard-derived approach to controlling unwanted pests and diseases.
MustGrow
has completed a series of application rate tests with Canada’s National
Research Council to determine the applicability of MustGrow’s natural
mustard-derived technology as a bio-pesticide. Using multiple application
methods, herbicidal control was achieved after only 72 hours – controlling the
trial plants from the root up. This strong data validates MustGrow’s natural
science-based approach, utilizing the mustard seed’s natural defence mechanism,
not only as a bio-pesticide, but also as a bio-herbicide.
MustGrow’s
intellectual property suite is a platform for several crop protection
categories, aiming to disrupt global agriculture markets that have
traditionally been dominated by chemistry-based products. This filing enhances
MustGrow’s current patent portfolio covering many crop protection
categories. MustGrow’s existing patent
portfolio protects both method-of-use
and composition-of-matter claims for
MustGrow’s signature mustard-derived approach to controlling unwanted pests,
diseases, and now weeds.
“The
efficacious properties of our active ingredient as a bio-pesticide,
bio-nematicide and bio-herbicide represent a key milestone for MustGrow,”
remarked MustGrow COO Colin Bletsky.
“MustGrow has plans to further expand our data set and focus testing on
hard to kill and herbicide-resistant weeds as well as to expand applications of
our remarkable natural mustard-based technology.”
Investor ideas
reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of
each country. Please read Investorideas.com privacy policy
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment